| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.097 | 0.08 |